CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,151,055 | +76.8% | 82,016 | +6.5% | 0.00% | 0.0% |
Q1 2023 | $1,782,273 | -1.1% | 76,988 | +12.0% | 0.00% | 0.0% |
Q4 2022 | $1,801,617 | +290.8% | 68,764 | +193.3% | 0.00% | – |
Q3 2022 | $461,000 | +85.9% | 23,448 | +66.0% | 0.00% | – |
Q2 2022 | $248,000 | -79.6% | 14,126 | -81.0% | 0.00% | – |
Q1 2022 | $1,217,000 | +65.6% | 74,414 | +65.3% | 0.00% | – |
Q4 2021 | $735,000 | +129.7% | 45,026 | +79.5% | 0.00% | – |
Q3 2021 | $320,000 | +1900.0% | 25,082 | +2131.5% | 0.00% | – |
Q2 2021 | $16,000 | +166.7% | 1,124 | +195.8% | 0.00% | – |
Q4 2020 | $6,000 | – | 380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |